BSN: Speaking/Presenting-Abstract/Poster at Mtg for Richard D Gill

Home

News

Calendar

Top 200 Orgs

Top Orgs by Specialty

People, Speakers

About Us

My Profile

How We Rank

What's My Rank?
      What's My Popularity Score?
      In My Orgs?
      In My Specialities?
      In My Geography?
      In My Age?

My Mentors, Collaborators,
Associates, Peers, Buddies

Keep Me Up To Date
Specialty, Keyword,
Geography

People Making News

Latest Research From
Meetings

Recent Postings

People of Consequence (74510)

1. Peter Kowey
Lankenau Hospital
2. Lawrence W. Bassett
University of California
3. Robert S Kerbel
University of Toronto
4. Yehuda Shoenfeld
Sheba Medical Center
5. Paul Weiss
Gala Biotech business unit of Cardinal Health

Orgs of Consequence (21209)

1. University of California
2. Harvard University
3. The Mayo Clinic
4. National Institutes of Health
5. University of California, San Francisco

Terms of Consequence

1. Cells
2. Cancer
3. Genetics
4. Molecular
5. Proteins

View Profile

Richard D Gill

No Speaking/Presenting-Abstract/Poster at Mtg

Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation	Event	Month, Year
RNAi’s IN PRECLINICAL AND CLINICAL DEVELOPMENT (14:10-18:15)	Inaugural Oligonucleotide-Based Therapeutics Oct(17-18)	October, 2007
RNAi’s IN PRECLINICAL AND CLINICAL DEVELOPMENT: The DNAi Company PNT2258 - To the Clinic or Bust! (15:45-16:15)	Inaugural Oligonucleotide-Based Therapeutics Oct(17-18)	October, 2007
Panel Discussion: Is the Drug Development Paradigm the Same for siRNAs and RNAi’s as compared to Other Drugs - What is the Same and What is Different? (17:45-18:15)	Inaugural Oligonucleotide-Based Therapeutics Oct(17-18)	October, 2007

BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.